Critical Reviews in Oncology / Hematology
Volume 76, Issue 2 , Pages 127-132 , November 2010

The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer

  • Alistair Ring

      Affiliations

    • Corresponding Author InformationTel.: +44 0 1273 696955; fax: +44 0 1273 623312.

,Accepted 6 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(10)00003-X

doi: 10.1016/j.critrevonc.2010.01.002

Critical Reviews in Oncology / Hematology
Volume 76, Issue 2 , Pages 127-132 , November 2010